Wandercraft today announced the acquisition of Ekso Bionics, Inc. from a subsidiary of ChronoScale Holdings Corporation (Nasdaq: CHRN), bringing together two leaders in robotic mobility. The two ...
By bringing its first patch pump to market, Beta Bionics will be able to compete with industry leader Insulet.
Zacks Investment Research on MSN
Beta Bionics stock down despite iLet-Eversense 365 integration deal
Beta Bionics, Inc. BBNX recently announced a partnership with Senseonics SENS to expand compatibility between its automated ...
The average one-year price target for Beta Bionics (NASDAQGM:BBNX) has been revised to $23.75 / share. This is an increase of 14.64% from the prior estimate of $20.72 dated September 11, 2026. These ...
One day after FDA cleared its Mint patch pump, Beta Bionics priced a $150 million stock offering and cut 2026 revenue guidance. · 7 sources across the spectrum on IJR News.
Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced that it plans to release its third quarter 2026 financial results ...
Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Beta Bionics, Inc. (“Beta Bionics” ...
Beta Bionics investors should visit us at or call toll-free (833) 538-3601. Lawyers at Kahn Swick & Foti, LLC are available to dicuss your legal options. About the Lawsuit Beta Bionics and certain of ...
Beta Bionics, Inc. ( BBNX) announced FDA clearance of Mint, its new patch pump featuring a reusable and disposable architecture, while unveiling 3D Intelligence, its next-generation insulin dosing ...
Eni (E) said Wednesday it signed an agreement with Generative Bionics, an Italian deep-tech firm specializing in humanoid robots powered by Physical AI, to evaluate potential areas of technological ...
Beta Bionics is currently trading at $20.37, up from the previous close of $19.23 after opening at $18.70 on the Nasdaq. The stock has traded between $18.62 and $21.00 during the session, with trading ...
This company is changing the way we see prostheses. Open Bionics is a UK-based start-up tech company. Its mission is to create affordable 3D printed prostheses. They are about 30 times cheaper than ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results